These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37239050)

  • 21. The multi-drug efflux system AcrABZ-TolC is essential for infection of
    Esteves NC; Porwollik S; McClelland M; Scharf BE
    J Virol; 2021 May; 95(11):. PubMed ID: 33731456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of
    Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacteriophages as Genomic Engineers and Anti-infective Weapons.
    Sullivan MR; Rubin EJ; Dulberger CL
    mBio; 2021 May; 12(3):. PubMed ID: 34006655
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
    Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
    Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption.
    Hesse S; Rajaure M; Wall E; Johnson J; Bliskovsky V; Gottesman S; Adhya S
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design combinations of evolved phage and antibiotic for antibacterial guided by analyzing the phage resistance of poorly antimicrobial phage.
    Xu Z; Ding Z; Shi L; Xie Y; Zhang Y; Sao S; Wang Q; Liu Q
    Microbiol Spectr; 2023 Sep; 11(5):e0095823. PubMed ID: 37707457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
    Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.
    Story-Roller E; Galanis C; Lamichhane G
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33361310
    [No Abstract]   [Full Text] [Related]  

  • 32. The Contribution of Efflux Pumps in
    Vianna JS; Machado D; Ramis IB; Silva FP; Bierhals DV; Abril MA; von Groll A; Ramos DF; Lourenço MCS; Viveiros M; da Silva PEA
    Antibiotics (Basel); 2019 Sep; 8(3):. PubMed ID: 31540480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection for Phage Resistance Reduces Virulence of Shigella flexneri.
    Kortright KE; Done RE; Chan BK; Souza V; Turner PE
    Appl Environ Microbiol; 2022 Jan; 88(2):e0151421. PubMed ID: 34788068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic Effects of Phage-Antibiotic Combinations against
    Manohar P; Madurantakam Royam M; Loh B; Bozdogan B; Nachimuthu R; Leptihn S
    ACS Infect Dis; 2022 Jan; 8(1):59-65. PubMed ID: 34979073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage resistance-mediated trade-offs with antibiotic resistance in Salmonella Typhimurium.
    Laure NN; Ahn J
    Microb Pathog; 2022 Oct; 171():105732. PubMed ID: 36002113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage Cocktail in Combination with Kasugamycin as a Potential Treatment for Fire Blight Caused by
    Kim SG; Lee SB; Jo SJ; Cho K; Park JK; Kwon J; Giri SS; Kim SW; Kang JW; Jung WJ; Lee YM; Roh E; Park SC
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities.
    Amarh ED; Dedrick RM; Garlena RA; Russell DA; Gauthier CH; Aull HG; Abad L; Jacobs-Sera D; Akusobi C; Rubin EJ; Hatfull GF
    PLoS One; 2023; 18(2):e0281769. PubMed ID: 36795728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
    Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.